Stage III Colon Cancer Prognosis Prediction by Tumor Gene Expression Profiling: 526Barrier, Alain J.Lemoine, AntoinetteDudoit, SandrineOfficial journal of the American College of Gastroenterology | ACG
PURPOSE: The aim of this study was to determine the prognosis of pN3 stage gastric cancer patients after they have undergone curative resection, and we also wanted to identify the prognostic factors according to the clinico-pathologic features. MATERIALS AND METHODS: Between January 2000 and Decembe...
If you have stage IVthyroid cancer, you may want to know about your prognosis -- an estimate of how serious the disease is and how it will affect you in the future. Your outlook depends on a lot of things, including the type of thyroid cancer you have, your age, and your overall he...
Your doctor will also do tests to make sure your cancer hasn't come back. Cancer that returns is called a recurrence.Colon canceris most likely to recur in the first 5 years after you're treated. If your cancer does come back, seeing your doctor regularly will help find it early, when...
Clinical stage T3N0 non-small cell lung cancer (NSCLC) has a better prognosis than other Stage IIIA lung cancersClinical stage T3N0 non-small cell lung cancer (NSCLC) has a better prognosis than other Stage IIIA lung cancersdoi:10.1016/0169-5002(94)94477-6None...
10 Background: In colon cancer, tumor deposits (TD) have been associated with worse prognosis, but they are included in the TNM staging system only in the absence of lymph node metastasis (i.e., stage III pN1c tumors). Here we aimed at evaluating the prognostic value of TD and the im...
Colorectal cancer (CRC) is the third most common cancer worldwide. Accurately identifying stage II CRC patients at risk for recurrence is an unmet clinical need. KCNQ1 was previously identified as a tumour suppressor gene and loss of expression was assoc
34 demonstrated that Bd is associated with a consensus molecular subtype 4, which represents EMT and cancer stem cell phenotype. In the study by Akabane et al.,17 Bd1 was associated with a favorable prognosis in patients with low-risk stage III CC, thus indicating that Bd could play a role...
Using the Lymph Node Ratio to Evaluate the Prognosis of Stage II/III Breast Cancer Patients Who Received Neoadjuvant Chemotherapy and Mastectomy PURPOSE: This study was conducted to investigate the prognostic value of lymph node ratio (LNR) in stage II/III breast cancer patients who undergo mastec...
MOC accounts for 3% [2] to 10% [3] of all ovarian carcinomas. Most patients with MOC are diagnosed at an early stage and therefore it confers a favorable prognosis [3]. However, once the disease is advanced, mucinous histology has a poorer outcome compared to the other histologic ...